Key facts
- Ceriter’s last known valuation is $2.7M (Dec 2024).
- It has raised $1.1M; the latest was Early Stage VC ($1.0M) in Dec 2024.
- Notable investors include Imec.istart, Flanders Investment & Trade, LIOF Nedermaas High Tech Ventures, Medlim, RDY — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Ceriter
- ·The full record, as it builds
Funding rounds
No funding rounds for Ceriter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ceriter
Developer of a medical device designed to help patients in gait rehabilitation recover their ability to walk. The company provides insights into gait patterns and provides real-time feedback for patients to practice more and its smart insole makes rehabilitation more efficient, enabling patients to easily recover from a cardiovascular accident and improve their quality of life.
- Sector
- Healthcare
- HQ
- Lanaken, Belgium
- Founded
- 2020
- Employees
- 7
- Website
- ceriter.com/
- Ownership
- Privately Held (backing)
Ceriter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ceriter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ceriter in its N-PORT filings yet. We sweep new filings monthly.